SOAT1 and breast cancer: Over the past decades, the limitations of cystoscopy, including invasiveness and high cost, have led to the development of several urinary-based diagnostic methods for BC surveillance, including urinary cytology10,19, fluorescence in situ hybridization20,21, urinary protein detection (BTA-STAT)22,23, NMP2224–26, and others27.